CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-26 | Hsieh Ming Chief Executive Officer | Grant or award | +13,090 | 645,792 | ||
| 2024-02-26 | Hsieh Ming Chief Executive Officer | Grant or award | +20,679 | 666,471 | ||
| 2024-02-26 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −6,997 | $24.26 | $170K | 659,474 |
| 2024-02-26 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −11,053 | $24.26 | $268K | 648,421 |
| 2024-02-26 | Hsieh Ming Chief Executive Officer | Grant or award | +65,952 | 714,373 | ||
| 2024-02-26 | Xie Jian President and COO | Grant or award | +3,927 | 343,037 | ||
| 2024-02-26 | Xie Jian President and COO | Grant or award | +6,359 | 349,396 | ||
| 2024-02-26 | Xie Jian President and COO | Shares withheld for taxes | −2,111 | $24.26 | $51K | 347,285 |
| 2024-02-26 | Xie Jian President and COO | Shares withheld for taxes | −3,418 | $24.26 | $83K | 343,867 |
| 2024-02-26 | Xie Jian President and COO | Grant or award | +25,350 | 369,217 | ||
| 2024-02-25 | Xie Jian President and COO | Shares withheld for taxes | −2,951 | $16.29 | $48K | 347,616 |
| 2024-02-25 | Xie Jian President and COO | Shares withheld for taxes | −8,031 | $16.29 | $131K | 339,585 |
| 2024-02-23 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −2,670 | $24.06 | $64K | 194,820 |
| 2024-02-23 | Xie Jian President and COO | Shares withheld for taxes | −2,612 | $24.06 | $63K | 339,110 |
| 2024-02-23 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −1,617 | $24.06 | $39K | 902,850 |
| 2024-02-23 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −8,667 | $24.06 | $209K | 632,702 |
| 2024-02-03 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −982 | $24.65 | $24K | 197,490 |
| 2024-02-03 | Xie Jian President and COO | Shares withheld for taxes | −6,719 | $24.65 | $166K | 351,722 |
| 2024-02-01 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −1,094 | $24.99 | $27K | 641,369 |
| 2024-01-30 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −90 | $25.00 | $2K | 904,467 |
Page 13 of 15 · 300 trades